News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
711,827 Results
Type
Article (42192)
Company Profile (440)
Press Release (669195)
Section
Business (208739)
Career Advice (2027)
Deals (36012)
Drug Delivery (103)
Drug Development (83548)
Employer Resources (173)
FDA (16407)
Job Trends (15093)
News (352753)
Policy (33052)
Tag
2024 BioCapital Digital (10)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (19)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (8)
2024 Pharm Country Standard (6)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (8)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2636)
Accelerated approval (3)
Adcomms (24)
Allergies (82)
Alliances (50913)
ALS (86)
Alzheimer's disease (1395)
Antibody-drug conjugate (ADC) (122)
Approvals (16394)
Artificial intelligence (242)
Autoimmune disease (16)
Automation (14)
Bankruptcy (371)
Best Places to Work (11848)
BIOSECURE Act (18)
Biosimilars (101)
Biotechnology (331)
Bladder cancer (61)
Brain cancer (24)
Breast cancer (252)
Cancer (2012)
Cardiovascular disease (158)
Career advice (1691)
Career pathing (30)
CAR-T (146)
Cell therapy (415)
Cervical cancer (17)
Clinical research (67447)
Collaboration (801)
Compensation (452)
Complete response letters (23)
COVID-19 (2643)
CRISPR (39)
C-suite (214)
Cystic fibrosis (103)
Data (1925)
Decentralized trials (2)
Denatured (26)
Depression (44)
Diabetes (246)
Diagnostics (6388)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (115)
Drug pricing (104)
Drug shortages (26)
Duchenne muscular dystrophy (90)
Earnings (87360)
Editorial (35)
Employer branding (21)
Employer resources (148)
Events (115134)
Executive appointments (642)
FDA (17515)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (716)
Gene editing (102)
Generative AI (19)
Gene therapy (295)
GLP-1 (717)
Government (4469)
Grass and pollen (4)
Guidances (48)
Healthcare (19139)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2774)
Inflammatory bowel disease (138)
Inflation Reduction Act (11)
Influenza (47)
Intellectual property (84)
Interviews (313)
IPO (16769)
IRA (43)
Job creations (3702)
Job search strategy (1437)
Kidney cancer (9)
Labor market (34)
Layoffs (477)
Leadership (17)
Legal (7977)
Liver cancer (71)
Lung cancer (293)
Lymphoma (131)
Machine learning (2)
Management (59)
Manufacturing (273)
MASH (62)
Medical device (13471)
Medtech (13476)
Mergers & acquisitions (19701)
Metabolic disorders (654)
Multiple sclerosis (69)
NASH (19)
Neurodegenerative disease (88)
Neuropsychiatric disorders (30)
Neuroscience (1890)
NextGen: Class of 2025 (6757)
Non-profit (4549)
Northern California (2413)
Now hiring (37)
Obesity (358)
Opinion (221)
Ovarian cancer (73)
Pain (79)
Pancreatic cancer (77)
Parkinson's disease (136)
Partnered (18)
Patents (202)
Patient recruitment (94)
Peanut (47)
People (58463)
Pharmaceutical (87)
Pharmacy benefit managers (19)
Phase I (21193)
Phase II (29763)
Phase III (22006)
Pipeline (984)
Podcasts (73)
Policy (115)
Postmarket research (2601)
Preclinical (9043)
Press Release (67)
Prostate cancer (94)
Psychedelics (37)
Radiopharmaceuticals (260)
Rare diseases (374)
Real estate (6011)
Recruiting (66)
Regulatory (22578)
Reports (46)
Research institute (2414)
Resumes & cover letters (352)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (69)
Series A (129)
Series B (83)
Service/supplier (12)
Sickle cell disease (54)
Southern California (2098)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (29)
Startups (3758)
State (2)
Stomach cancer (13)
Supply chain (60)
The Weekly (44)
United States (21410)
Vaccines (672)
Venture capitalists (38)
Webinars (13)
Weight loss (244)
Women's health (35)
Worklife (16)
Date
Last 7 days (576)
Last 30 days (2465)
Last 365 days (34509)
2025 (7850)
2024 (36319)
2023 (41029)
2022 (52292)
2021 (56777)
2020 (54942)
2019 (47454)
2018 (35727)
2017 (33039)
2016 (32361)
2015 (38409)
2014 (32194)
2013 (27126)
2012 (29230)
2011 (29868)
2010 (27995)
Location
Africa (736)
Alabama (54)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (39129)
Australia (6508)
California (5571)
Canada (1864)
China (476)
Colorado (251)
Connecticut (269)
Delaware (126)
Europe (85416)
Florida (813)
Georgia (190)
Idaho (58)
Illinois (506)
India (23)
Indiana (292)
Iowa (10)
Japan (140)
Kansas (103)
Kentucky (24)
Louisiana (8)
Maine (60)
Maryland (843)
Massachusetts (4254)
Michigan (210)
Minnesota (372)
Mississippi (2)
Missouri (76)
Montana (29)
Nebraska (25)
Nevada (56)
New Hampshire (66)
New Jersey (1580)
New Mexico (30)
New York (1583)
North Carolina (975)
North Dakota (7)
Northern California (2413)
Ohio (193)
Oklahoma (14)
Oregon (37)
Pennsylvania (1252)
Puerto Rico (9)
Rhode Island (27)
South America (1110)
South Carolina (18)
South Dakota (1)
Southern California (2098)
Tennessee (92)
Texas (830)
Utah (166)
Virginia (131)
Washington D.C. (59)
Washington State (525)
West Virginia (3)
Wisconsin (49)
711,827 Results for "agile therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Press Releases
Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
March 25, 2025
·
3 min read
Press Releases
Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
March 20, 2025
·
3 min read
Press Releases
Agilent Research Catalyst Award Presented to Columbia University for Professor Pawel Muranski
March 19, 2025
·
4 min read
Business
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.
August 26, 2024
·
5 min read
Business
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Agile Therapeutics, Inc. (Pink: AGRX), a women’s healthcare company, today reported financial results for the three months ended March 31, 2024 and provided a corporate update.
May 15, 2024
·
14 min read
Press Releases
Agilent to Participate in TD Cowen Health Care Conference
February 27, 2025
·
1 min read
Policy
Agile Therapeutics Announces Delisting from Nasdaq - March 25, 2024
Agile Therapeutics, Inc., a women’s healthcare company, announced that the Company has received a final delisting notice from Nasdaq.
March 25, 2024
·
4 min read
Pharm Country
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
Agile Therapeutics, Inc., a women’s healthcare company, announced that it has paid-off the remainder of its debt facility with Perceptive Advisors.
March 13, 2024
·
3 min read
Business
Padraig McDonnell Assumes Agilent CEO Role
Agilent Technologies Inc. announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately.
May 1, 2024
·
2 min read
1 of 71,183
Next